- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05893433
Bedside Cycling Exercises Post Heart Valve Surgeries
Effect of Early Bedside Cycling Exercises on Selected Physical and Psychological Outcomes in Patients After Heart Valve Surgery
The aim of this clinical trial is to assess the effect of early bedside cycling exercises post heart valve surgeries. the main question aims to answer: whether adding an early bedside cycling exercise will have an effect on patient's functional capacity, other physical outcomes and have an effect on patient's psychological state?
The participant will be assessed blindly the physical and psychological outcomes before getting randomly allocated in groups. the bedside cycling will be introduced and conducted in the intervention group in addition to the conventional physical therapy cardiac rehabilitation routine through preexisted physical therapy staff who present the hospital:
The routine use of breathing exercises, coughing techniques, chest wall vibrations, and mobilization is common during the first postoperative days.
On the other hand, the control group will only receive the conventional rehabilitation, subsequently, both groups will be assessed and compared by addressing the difference of the outcomes before discharging from the hospital.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The aim of the study is to assess the effect of early bedside cycling exercises on selected physical and psychological outcomes in patients after heart valve surgery.
This study will be carried out on fifty patients diagnosed with valve heart disease and undergoing valve replacement or intervention. They will be recruited from National Heart Institute-Cairo, Egypt.
The purpose, nature and the risk of the study will be explained to the patients and each patient will be consented prior to participation in the study.
The patients in this study will randomly be assigned and randomly allocated into two equal groups (n=25), the intervention group will be treated daily from being extubated and being relatively stable until discharge from the hospital:
- Study group (25 patients): will receive bedside cycling in addition to the medical treatment and physiotherapy protocol.
- Control group (25 patients): will receive only routine physiotherapy treatment protocol and the medical treatment.
The bedside cycling will be introduced and conducted in the intervention group in addition to the conventional phase one of cardiac rehabilitation program through preexisted physical therapy staff who present the hospital.
Bedside cycling: once the patient is relatively stable by weaning off the ventilator and off the require inotropic support and continued until the discharge from the hospital.
Intensity:
- Rating of Perceived exertion scale (RPE) from 11 to 13 (scale 6-20)
- post-surgery: resting HR + 20-30 bpm (up to tolerance if non-symptomatic), from low intensity and progressed to medium intensity (According to The American College of Sports Medicine (ASCM) recommendations for prescription of the exercises in phase one of cardiac rehabilitation).
Duration:
- Session duration: Total duration of 20 min, early morning.
- Intervention duration: 5-15
- Resting as the patient wishes and in case signs of exertion.
- Warming up for 5min: low impact, dynamic movement of large group of muscles through available Active Range of Motion (ROM) or introduce to cycling, HR after warming up 10-11 RPE
- Cooling down for 5 min or longer: patient observed 30 min after exercise to get to Resting Heart Rate (RHR)
- Guided by 11-13 RPE, talk test, 20-30 bpm above RHR (Target HR) and sign and symptoms for stopping exercise. According ASCM recommendations for prescription of the exercises in phase one of cardiac rehabilitation.
- Frequency: once daily from medically stable until discharge.
Progression if the following conditions are reached:
- Initially increase the duration by up to15 min of low exercise time and then increase the intensity after the patient can complete 15- 20 min.
- Complete 15min with a medially stable condition
Precaution:
- Vital signs before after and within range
Avoid Valsalva maneuver.
On the other hand, the control group will only receive the conventional rehabilitation routine:
- The routine use of breathing exercises, coughing techniques, chest wall vibrations, and mobilization is common during the first postoperative days.
Subsequently, both groups will be assessed and compared by addressing the difference of the outcomes before discharging from the hospital.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Salwa A Milegy, TA
- Phone Number: +201008141534
- Email: salwa.asem@cu.edu.eg
Study Contact Backup
- Name: AHMAD M AHMAD, Asst. Prof.
- Phone Number: +201007056624
- Email: ahmed.mahdy@pt.cu.edu.eg
Study Locations
-
-
-
Giza, Egypt, 12651
- National Heart Institute (NHI)
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Fifty patients with valvular heart disease (VHD)who have undergone valve surgical intervention
- Their age between 20-40 years old.
- Both genders
Exclusion Criteria:
- Cognitive impairment.
- Neurological disorders.
- Sever Musculoskeletal disorders (MSD) e.g. (late stages of osteoarthritis).
- Underlying pulmonary diseases (aspiration pneumonia, chronic obstructive pulmonary disease, pneumothorax, etc).
Presence of comorbidities like:
- Liver disease e.g. Active cirrhosis or history of previous liver transplant.
- Renal disease e.g. Chronic renal disease, Renal failure.
- Complicated operative course: post-operative complication:
a) Presence of preoperative cofounder complication: pulmonary hypertension (Pulmonary artery pressure) = which estimated by right ventricular systolic pressure (RVSP) is greater than 50 mmHg, left ventricular dysfunction which estimated left ventricular ejection fraction equals 40 % or less.
b) Patients with Coronary artery bypass surgery, active infective endocarditis, acute valve dysfunction and other acute urgent conditions.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Bedside cycling Group
Participants (25 patients) that will receive bedside cycling:
|
participants receive daily cycling once the patient is relatively stable by weaning off the ventilator and off the require inotropic support and continued to the discharge from the hospital. Duration progression if the following conditions are reached:
|
Placebo Comparator: Routine physical therapy Group
participant that will receive only routine physiotherapy treatment protocol and the medical treatment.
|
the routine physical therapy protocol of breathing exercises, coughing techniques, chest wall vibrations, and mobilization is common during the first postoperative days, The two most frequently used breathing techniques were deep breathing exercises and incentive spirometry and the medical treatment.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Functional capacity
Time Frame: from the date of patient admission to the hospital until date of the surgical operation, an average of 2 weeks.
|
measured by Six Minutes Walk Test, it will be performed on a flat surface, with a predetermined distance 30 meters measured and marked off.
Patients will be asked to walk self-paced back and forth between the 2 marked points for 6 minutes.
Rests are allowed, and administrators are able to provide standardized feedback during and at the end of the test, The laps are counted, and a distance walked in 6 minutes is determined.
|
from the date of patient admission to the hospital until date of the surgical operation, an average of 2 weeks.
|
Functional capacity
Time Frame: through study completion, an average of 2 weeks.
|
measured by Six Minutes Walk Test, it will be performed on a flat surface, with a predetermined distance 30 meters measured and marked off.
Patients will be asked to walk self-paced back and forth between the 2 marked points for 6 minutes.
Rests are allowed, and administrators are able to provide standardized feedback during and at the end of the test, The laps are counted, and a distance walked in 6 minutes is determined.
|
through study completion, an average of 2 weeks.
|
Forced Vital Capacity
Time Frame: from the date of patient admission to the hospital until date of the surgical operation, an average of 2 weeks.
|
measured by Spirometry Pulmonary function test, (THOR laboratory Spiro Tube PC Spirometer) will assess Forced Vital Capacity (FCV) in liters.
|
from the date of patient admission to the hospital until date of the surgical operation, an average of 2 weeks.
|
Forced Vital Capacity
Time Frame: through study completion, an average of 2 weeks.
|
measured by Spirometry Pulmonary function test, (THOR laboratory Spiro Tube PC Spirometer) will assess Forced Vital Capacity (FCV) in liters.
|
through study completion, an average of 2 weeks.
|
Psychological status
Time Frame: from the date of patient admission to the hospital until date of the surgical operation, an average of 2 weeks.
|
The Depression Anxiety Stress Scales 42 were used to measure three negative emotional states (depression, anxiety, and stress) experienced by the patients in the previous week.
A higher score on the scale indicates a more severe condition, with the highest possible score being 126 and the lowest score being 0.
|
from the date of patient admission to the hospital until date of the surgical operation, an average of 2 weeks.
|
Psychological status
Time Frame: through study completion, an average of 2 weeks.
|
The Depression Anxiety Stress Scales 42 were used to measure three negative emotional states (depression, anxiety, and stress) experienced by the patients in the previous week.
A higher score on the scale indicates a more severe condition, with the highest possible score being 126 and the lowest score being 0.
|
through study completion, an average of 2 weeks.
|
Activities of Daily Living and Functional level
Time Frame: within the first 24-hour post-surgery
|
measuring Activities of Daily Living and Function level by using Barthel Index, the current level of 10 items the maximum score is 100, the lower scores ranging from 0- 20 indicating increased disability.
|
within the first 24-hour post-surgery
|
Activities of Daily Living and Functional level
Time Frame: through study completion, an average 7 days
|
measuring Activities of Daily Living and Function level by using Barthel Index, the current level of 10 items the maximum score is 100, the lower scores ranging from 0- 20 indicating increased disability.
|
through study completion, an average 7 days
|
the Quality of Life
Time Frame: from the date of patient admission to the hospital until date of the surgical operation, an average of 2 weeks.
|
The Short Form-12 Health Questionnaire was used to measure the Quality of Life over the past 4 weeks, consisting of two components: physical and mental.
The highest possible score for the mental component was 60.75781, indicating a better mental condition.
Similarly, the highest possible score for the physical component was 56.577706, indicating a better physical condition.
|
from the date of patient admission to the hospital until date of the surgical operation, an average of 2 weeks.
|
Length of hospital stay
Time Frame: through study completion, an average of 2 weeks.
|
compare the intervention group to control group length of hospital stay.
|
through study completion, an average of 2 weeks.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Functional Capacity
Time Frame: 1 month follow-up.
|
measured by Six Minutes Walk Test (6MWT), it will be performed on a flat surface, with a predetermined distance 30 meters measured and marked off.
Patients will be asked to walk self-paced back and forth between the 2 marked points for 6 minutes.
Rests are allowed, and administrators are able to provide standardized feedback during and at the end of the test, The laps are counted, and a distance walked in 6 minutes is determined.
|
1 month follow-up.
|
Psychological status
Time Frame: 1 month follow-up.
|
The Depression Anxiety Stress Scales 42 were used to measure three negative emotional states (depression, anxiety, and stress) experienced by the patients in the previous week.
A higher score on the scale indicates a more severe condition, with the highest possible score being 126 and the lowest score being 0.
|
1 month follow-up.
|
the Quality of Life
Time Frame: 1 month follow-up.
|
The Short Form-12 Health Questionnaire was used to measure the Quality of Life over the past 4 weeks, consisting of two components: physical and mental.
The highest possible score for the mental component was 60.75781, indicating a better mental condition.
Similarly, the highest possible score for the physical component was 56.577706, indicating a better physical condition.
|
1 month follow-up.
|
Incidence of adverse event
Time Frame: from the date of beginning cycling intervention or routinely physiotherapy until the date of discharge and will be assessed up to one month.
|
the potential incidence of adverse events in both groups will be reported during the study.
|
from the date of beginning cycling intervention or routinely physiotherapy until the date of discharge and will be assessed up to one month.
|
Prothrombin International Normalized Ratio (INR)
Time Frame: 1 month follow-up.
|
Prothrombin International Normalized Ratio (INR) in the Coagulation profile in both groups will be assessed and provided at one-month follow-up.
|
1 month follow-up.
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- cycling valve surgery
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Valve Diseases
-
National Heart, Lung, and Blood Institute (NHLBI)WithdrawnHeart Failure | Aortic Valve Stenosis | Mitral Valve Regurgitation | Heart Valve Disease | Tricuspid Valve RegurgitationUnited States
-
Medical College of WisconsinChildren's Hospital and Health System Foundation, WisconsinCompletedMitral Valve Regurgitation | Tricuspid Valve Regurgitation, Non-rheumaticUnited States
-
UMC UtrechtLeiden University Medical Center; The Interuniversity Cardiology Institute... and other collaboratorsTerminatedMitral Valve Insufficiency | Diseases of Mitral Valve | Heart; Disease, Mitral(Valve)Netherlands
-
Edwards LifesciencesActive, not recruitingHeart Failure | Mitral Valve Insufficiency | Mitral Valve Regurgitation | Mitral Valve DiseaseUnited States, Australia, Brazil
-
Assistance Publique Hopitaux De MarseilleSuspendedAortic Valve Regurgitation AcquiredFrance
-
Edwards LifesciencesRecruitingCardiovascular Diseases | Heart Failure | Heart Valve Diseases | Tricuspid Valve Regurgitation | Tricuspid Valve Insufficiency | Tricuspid Valve DiseaseUnited States, Germany
-
Synecor, LLCUnknownHeart Failure | Mitral Valve Insufficiency | Mitral Valve Regurgitation | Mitral Valve Disease
-
Caisson Interventional LLCActive, not recruitingMitral Regurgitation | Valve Disease, Heart | Valve Heart Disease | Mitral Valve Disease | Mitral Valve Failure | Mitral DiseaseUnited States
-
Maria Cecilia HospitalRecruiting
-
Universitätsklinikum Hamburg-EppendorfRecruitingAortic Valve Disease | Heart Valve Diseases | Mitral Valve Disease | Tricuspid Valve DiseaseGermany
Clinical Trials on Bedside cycling
-
Hamilton Health Sciences CorporationCompletedCritical Illness | Critical Illness Myopathy | Thoracic Surgery | Cardiac Disease | Critical Illness PolyneuropathyCanada
-
Humanitas Clinical and Research CenterRecruitingCritical Illness | Mechanical Ventilation Complication | Weaning Failure | Diastolic Heart Failure | Diastolic DysfunctionItaly
-
University Hospital, GhentUniversity GhentCompletedPatient Participation | Nursing | Bedside Shift ReportBelgium
-
The Hospital for Sick ChildrenOntario Ministry of Health and Long Term CareCompletedClinically Deteriorating Paediatric PatientsCanada
-
George Fox UniversityRecruitingCan BFR Cycling Augment Strength and VO2peakUnited States
-
Verein zur Förderung der Rehabilitationsforschung...Deutsche Arthrose-Hilfe; Verein zur Förderung der Erforschung und Bekämpfung... and other collaboratorsCompleted
-
UGECAM Rhône-AlpesRecruitingHemiparesis;Poststroke/CVAFrance
-
Université Catholique de LouvainRecruiting
-
Timothy GleesonAngkor Hospital for ChildrenCompletedFever | DengueCambodia
-
Azienda Ospedaliero-Universitaria CareggiCompletedAbdominal Pain | Acute DiverticulitisItaly